Navigation Links
Major New Resource for Bone and Mineral Disorders Released
Date:12/9/2008

Medical Reference and Online Edition Gives Coverage of Bone and Mineral Diseases and Disorders with New International Drug Formulary

WASHINGTON, Dec. 9 /PRNewswire/ -- The American Society for Bone and Mineral Research (ASBMR), the leading scientific organization for the study of bone diseases, announces the publication of the new seventh edition of the Primer on the Metabolic Bone Diseases and Disorders of Bone and Mineral Metabolism. The new edition reflects the rapid and exciting advances in research and the clinical practice management of diseases such as osteoporosis, metastatic bone diseases and inherited bone diseases. Earlier editions of this widely used text have proven to be an indispensable and trusted resource for medical students, residents, physicians and scientists involved in bone and mineral diseases and disorders.

The Primer presents the most current findings on diagnosis, laboratory evaluation, treatment, clinical presentations, risk factors and bone density characteristics of osteoporosis, primary hyperparathyroidism, Paget's disease of bone, childhood rickets, renal osteodystrophy and metastatic bone disease. The increased use of reference images in this edition provides material on the differential diagnosis of rare diseases or bone cancers that may present with common symptoms.

"Our goal with the Seventh Edition of the Primer was to create a worldwide perspective on the diseases and disorders of bone," said Primer Editor-in-Chief, Clifford Rosen, M.D., Director of Clinical and Translational Research at Maine Medical Center. "This book is a 'must have' resource for all clinicians involved with the diagnosis and treatment of patients with bone diseases, especially osteoporosis, other metabolic bone diseases and bone cancer."

Bone disease reaches across many specialties and disciplines, and this new edition is an excellent overview to metabolic bone disease in a concise, current and usable format. Physicians and scientists in internal medicine, pediatrics, orthopedics, primary care, geriatrics, obstetrics and gynecology, endocrinology, rheumatology, oncology and nephrology will benefit from the information provided here.

New material added to this edition includes:

  • Abnormalities in Bone and Calcium Metabolism Following Burns
  • Bone Cancer and Pain
  • Vascular Calcification
  • Bisphosphonate-Associated Osteonecrosis of the Jaw
  • New International Drug Formulary covering the most widely used drugs in major regions of the world

The highly regarded Primer was first published in 1990, with subsequent editions released every three years to reflect progress and new research in the bone field.

Of the sixth edition, customers have commented:

"I highly recommend this book ... to any physician caring for patients with bone diseases ... "

The ASBMR is the premier professional, scientific and medical society for the promotion of bone and mineral research and the translation of that research into clinical practice. To learn more, visit the ASBMR website at www.asbmr.org.

Copies of the print edition are available at medical bookstores, Amazon.com, or direct from ASBMR. To order, send email to primer@jbmr.org or download an order form at www.asbmrprimer.org. Site licenses for the Online Edition will also be available for institutional users.


'/>"/>
SOURCE American Society for Bone and Mineral Research
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Dr. Jane L. Delgado Appointed By Senate Majority Leader to Board of National Urban Air Toxics Research Center
2. Major Retailers Experience 161% Increase in Attempted Hacker Attacks, According to SecureWorks
3. NUCRYST Receives Requisition to Call a Special Meeting of Shareholders From Majority Shareholder
4. Mini heart attacks lessen damage from major ones
5. Major North American breakthrough for dialysis patients
6. Labopharm to host webcast presentation on novel trazodone formulation for treatment of major depressive disorder
7. New Survey Shows Majority of Americans Need to Take Proper Steps to Manage Diabetes Risk
8. Hospital of the Future Report Urges Major Changes
9. America Reaches Major Anti-Smoking Milestone
10. Insure.com Examines Major Medical Mistakes Called Never Events
11. Employers Want National Approach to Health Care—Still Believe Employer-Based System Works Best: New Survey Looks At Attitudes toward Health Care Reform and Major Health Care Issues.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... (PRWEB) , ... June 27, ... ... in the patient payment industry today announced its strategic partnership with Connance, ... system workflows. , The two companies’ proven, proprietary technology combine to provide ...
(Date:6/26/2016)... California (PRWEB) , ... June 26, 2016 , ... Pixel ... Cut Pro X. , "Film editors can give their videos a whole new perspective ... Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels contains over ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is ... associated with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: